Clinical Effect of Lifestyle Modification on Cardiovascular Risk in Prehypertensives: PREHIPER I Study;Eficacia clínica de la modificación del estilo de vida en el riesgo cardiovascular en prehipertensos: estudio PREHIPER I

Revista Espanola de Cardiologia

Volumn 62, Issue 1, 2009, Pages 86-90

  Márquez Celedonio, Félix G ^a   Téxon Fernández, Obdulia ^a   Chávez Negrete, Adolfo ^b   Hernández López, Sergio ^c   Marín Rendón, Sadoc ^a   Berlín Lascurain, Susana ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Hospital de Especialidades del CMN Siglo XXI IMSS México DF   (Mexico)

^c UNIVERSIDAD VERACRUZANA   (Mexico)

Author keywords

Blood pressure; Cardiovascular disease; Exercise; Lifestyle

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; EXERCISE; FEMALE; HUMAN; LIFESTYLE; LIFESTYLE MODIFICATION; MALE; PATIENT EDUCATION; PHYSICAL ACTIVITY; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MEXICO; MIDDLE AGED; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SMOKING CESSATION;

EID: 59749089261     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)70025-9     Document Type: Article

References (15)

1. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Pressure. The JNC 7 Report. JAMA 289 (2003) 2560-2571
2. Wilson P., D'Agostino R., Levy D., Belanger A., Silbershatz H., and Kannel W. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
3. Grotto I., Grossman E., Huerta M., and Sharabi Y. Prevalence of prehypertension and asocciated cardiovascular risk profiles among young israeli adults. Hypertension 48 (2006) 254
4. Khot U.M., Khot M.B., Bajzer C.T., Sapp S.K., Ohman E.M., Brener S.J., et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 290 (2003) 898-904
5. Anderson K.M., Wilson P.W.F., Odell P.M., and Kannel W.B. An update coronary risk profile. A stament for health professionals. Circulation 83 (1991) 356-362
6. Shaper A.G., Pococok S.J., Philips A.N., and Walter M. Identifying men at high risk of heart attacks: stategy for use in general practice. Br Med J 293 (1986) 474-479
7. Sans S., Fitzgerald A., Royo J., Conroy R., and Graham I. Calibración de la tabla SCORE del riesgo cardiovascular para España. Rev Esp Cardiol 60 (2007) 476-485
8. Conroy P., Pyörala K., Fitzgerald A., Sans S., Menotti A., De Backer, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24 (2003) 987-1003
9. Martin J.E., Dubbert P.M., and Cushman W.C. Controlled trial of aerobic exercise in hypertension. Circulation 81 (1990) 1560-1567
10. Appel L.J., Moore T.J., Obarzanek E., Vollmer W.M., Svetkey L.P., Sacks F.M., et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 336 (1997) 1117-1124
11. PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on blood pressure control. JAMA 289 (2003) 2083-2093
12. Rodríguez M., López C., Munguía M., Hernández S., and Martínez B. Validez y consistencia del instrumento FANTASTIC para medir estilo de vida en diabéticos. Rev Med IMSS 41 (2003) 211-220
13. The Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. Arch Intern Med 157 (1997) 657-667
14. Sacks F.M., Svetkey L.P., Vollmer W.M., Appel L.J., Bray G.A., Harsha D., et al., For the DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 344 (2001) 3-10
15. Wister A., Loewen N., Kennedy-S H., McGowan B., McCoy B., and Singer J. One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. CMAJ 177 (2007) 859-865